Free Trial

Mangoceuticals (MGRX) Short Interest Ratio & Short Volume

Mangoceuticals logo
$1.48 -0.10 (-6.33%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$1.61 +0.13 (+8.78%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mangoceuticals Short Interest Data

Mangoceuticals (MGRX) has a short interest of 277,500 shares, representing 9.16% of the float (the number of shares available for trading by the public). This marks a 60.31% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 215,115 shares to cover all short positions.

Current Short Interest
277,500 shares
Previous Short Interest
173,100 shares
Change Vs. Previous Month
+60.31%
Dollar Volume Sold Short
$460,650.00
Short Interest Ratio
1.0 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
5,169,000 shares
Float Size
3,030,000 shares
Short Percent of Float
9.16%
Today's Trading Volume
86,438 shares
Average Trading Volume
215,115 shares
Today's Volume Vs. Average
40%
Short Selling Mangoceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Mangoceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MGRX Short Interest Over Time

MGRX Days to Cover Over Time

MGRX Percentage of Float Shorted Over Time

Mangoceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2025277,500 shares $460,650.00 +60.3%9.2%1 $1.66
4/15/2025173,100 shares $346,200.00 -29.3%5.7%0.7 $2.00
3/31/2025244,900 shares $477,555.00 +237.3%7.1%1.6 $1.95
3/15/202572,600 shares $283,866.00 +15.8%2.5%0.5 $3.91
2/28/202562,700 shares $258,951.00 -12.3%2.6%0.6 $4.13
2/15/202571,500 shares $346,060.00 +91.7%5.9%0.7 $4.84
1/31/202537,300 shares $113,019.00 +63.6%3.1%0.4 $3.03
1/15/202522,800 shares $58,140.00 -46.0%1.9%0.2 $2.55
12/31/202442,200 shares $102,124.00 -23.1%2.4%0.3 $2.42
12/15/202454,900 shares $143,289.00 -55.8%4.0%0.1 $2.61
11/30/2024124,200 shares $310,500.00 -18.8%9.1%0.3 $2.50
11/15/2024152,900 shares $353,199.00 -21.4%11.2%0.4 $2.31
10/31/2024194,400 shares $460,728.00 +839.1%15.3%0.6 $2.37
10/15/202420,700 shares $822,514.50 -79.6%1.6%0.1 $39.74
9/30/2024101,600 shares $23,977.60 -50.2%0.5%0 $0.24
9/15/2024203,900 shares $55,053.00 +62.1%1.1%0.2 $0.27
8/31/2024125,800 shares $30,179.42 -72.8%0.8%0.1 $0.24
8/15/2024462,500 shares $148,000.00 +138.7%2.8%0.3 $0.32
7/31/2024193,800 shares $79,070.40 -70.5%1.4%0 $0.41
7/15/2024657,700 shares $253,740.66 +430.8%4.7%0.1 $0.39
6/30/2024123,900 shares $37,665.60 -40.0%0.9%0 $0.30
6/15/2024206,500 shares $66,059.35 +67.9%1.5%0 $0.32
5/31/2024123,000 shares $48,412.80 +353.9%0.9%0 $0.39
5/15/202427,100 shares $5,934.90 -40.7%0.2%0 $0.22
4/30/202445,700 shares $11,109.67 -76.9%0.3%0.1 $0.24
4/15/2024197,600 shares $48,214.40 -71.5%1.5%0.2 $0.24
3/31/2024692,100 shares $150,117.18 +364.2%5.3%0.6 $0.22
3/15/2024149,100 shares $26,405.61 +16.0%1.2%0.1 $0.18
2/29/2024128,500 shares $28,861.10 -81.0%1.1%0.1 $0.22
2/15/2024674,500 shares $158,844.75 +75.4%5.5%0.8 $0.24
1/31/2024384,500 shares $138,804.50 +104.0%4.0%0.5 $0.36
1/15/2024188,500 shares $57,492.50 +195.0%2.6%0.3 $0.31
12/31/202363,900 shares $17,693.91 -57.9%0.9%0.1 $0.28
12/15/2023151,800 shares $46,602.60 +204.8%2.1%0.4 $0.31
11/30/202349,800 shares $36,802.20 +333.0%0.7%0.2 $0.74
11/15/202311,500 shares $5,012.85 -90.4%0.2%0 $0.44
10/31/2023120,300 shares $75,789.00 +620.4%1.7%0.5 $0.63
10/15/202316,700 shares $10,688.00 +153.0%0.2%0.1 $0.64
9/30/20236,600 shares $5,613.30 -82.8%0.1%0.1 $0.85
9/15/202338,400 shares $38,016.00 +18.5%0.6%0.4 $0.99
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
8/31/202332,400 shares $40,176.00 -22.5%0.5%0 $1.24
8/15/202341,800 shares $45,562.00 +5.8%0.6%0 $1.09
7/31/202339,500 shares $45,030.00 -13.9%0.6%0 $1.14
7/15/202345,900 shares $77,112.00 -51.9%0.8%0 $1.68
6/30/202395,400 shares $174,582.00 -79.6%1.6%0 $1.83
6/15/2023468,400 shares $726,020.00 +187.5%7.8%0.2 $1.55
5/31/2023162,900 shares $182,448.00 +10.4%2.9%0 $1.12
5/15/2023147,500 shares $181,425.00 No Change2.6%0 $1.23

MGRX Short Interest - Frequently Asked Questions

What is Mangoceuticals' current short interest?

Short interest is the volume of Mangoceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 277,500 shares of MGRX short. 9.16% of Mangoceuticals' shares are currently sold short. Learn More on Mangoceuticals' current short interest.

What is a good short interest ratio for Mangoceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MGRX shares currently have a short interest ratio of 1.0. Learn More on Mangoceuticals's short interest ratio.

What is a good short interest percentage for Mangoceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.16% of Mangoceuticals' floating shares are currently sold short.

Is Mangoceuticals' short interest increasing or decreasing?

Mangoceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 277,500 shares, an increase of 60.3% from the previous total of 173,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Mangoceuticals' float size?

Mangoceuticals currently has issued a total of 5,169,000 shares. Some of Mangoceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mangoceuticals currently has a public float of 3,030,000 shares.

How does Mangoceuticals' short interest compare to its competitors?

9.16% of Mangoceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Mangoceuticals: Burning Rock Biotech Limited (0.44%), Enzo Biochem, Inc. (0.97%), BioRestorative Therapies, Inc. (3.18%), Ontrak, Inc. (0.53%), BioNexus Gene Lab Corp. (4.36%), Aclarion, Inc. (10.15%), Vsee Health, Inc. (0.53%), ATI Physical Therapy, Inc. (5.31%), NewGenIvf Group Limited (0.73%), IMAC Holdings, Inc. (2.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Mangoceuticals stock?

Short selling MGRX is an investing strategy that aims to generate trading profit from Mangoceuticals as its price is falling. MGRX shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mangoceuticals?

A short squeeze for Mangoceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MGRX, which in turn drives the price of the stock up even further.

How often is Mangoceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGRX, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:MGRX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners